Grand jury probing meningitis-linked pharmacy: newspaper

BOSTON Sat Dec 1, 2012 9:52am EST

A Framingham Motorcycle Unit officer stands by while federal agents search New England Compounding Center in Framingham, Massachusetts October 16, 2012. The pharmaceutical compounding company is a producer of the steroid methylprednisolone acetate, which is a drug linked to a rare form of meningitis that has killed 16 people and sickened more than 200 others, the Virginia Department of Health said in a statement on Tuesday. REUTERS/Dominick Reuter

A Framingham Motorcycle Unit officer stands by while federal agents search New England Compounding Center in Framingham, Massachusetts October 16, 2012. The pharmaceutical compounding company is a producer of the steroid methylprednisolone acetate, which is a drug linked to a rare form of meningitis that has killed 16 people and sickened more than 200 others, the Virginia Department of Health said in a statement on Tuesday.

Credit: Reuters/Dominick Reuter

Related Topics

BOSTON (Reuters) - A grand jury is investigating the compounding pharmacy at the heart of a deadly meningitis outbreak, the Boston Globe reported on Saturday.

The grand jury has begun issuing subpoenas to people who worked for the New England Compounding Center, which closed after investigators determined it had produced the tainted injectible steroid that has killed 36 people, the newspaper reported, citing unnamed people who formerly worked for the company.

Grand jury investigations, which are conducted in secrecy, are a step prosecutors take before determining whether to press criminal charges.

Officials at the U.S. Attorney's office and NECC could not be reached for immediate comment on Saturday. The Globe reported that U.S. officials declined to comment.

After federal officials in October raided the Framingham, Massachusetts-based pharmacy, U.S. Attorney Carmen Ortiz confirmed her office was investigating the company.

U.S. District Court Judge Dennis Saylor, who is hearing the dozen civil lawsuits filed against NECC in federal court in Boston, said during a Wednesday hearing there may be a grand jury investigation into the company.

(Reporting By Scott Malone; Editing by Vicki Allen)

FILED UNDER:
We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (1)
nerdpocalypse wrote:
Compounding pharmacies mix up very boring combinations of FDA approved, FDA manufacturing supervised pharmaceuticals. I asked one to make a mixture of silvadene and lidocaine for someone with a painful burn. They are under physician orders/direct supervision for individual patients. Nearly always for use outside the body.

They broke so many federal laws here…to make a tiny amt of money…… and people died. They’re looking for possibility of death penalty.

Dec 01, 2012 7:42pm EST  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

Full focus